Key statistics
On Monday, Amylyx Pharmaceuticals Inc (AMLX:NSQ) closed at 3.08, 95.56% above the 52 week low of 1.58 set on Jun 17, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 3.11 |
---|---|
High | 3.18 |
Low | 3.04 |
Bid | 3.08 |
Offer | 3.15 |
Previous close | 3.12 |
Average volume | 1.04m |
---|---|
Shares outstanding | 68.08m |
Free float | 58.31m |
P/E (TTM) | -- |
Market cap | 212.42m USD |
EPS (TTM) | -2.45 USD |
Data delayed at least 15 minutes, as of Oct 07 2024 21:00 BST.
More ▼
Press releases
- Amylyx Pharmaceuticals to Participate in Upcoming Investor Conferences
- Amylyx Pharmaceuticals Announces Publication of Data Showing the Encouraging Effects of AMX0035 on Cerebrospinal Fluid Biomarkers of Core Alzheimer’s Disease Pathology and Neurodegeneration
- Amylyx Pharmaceuticals Reports Second Quarter 2024 Financial Results
- Amylyx Pharmaceuticals to Report Second Quarter 2024 Financial Results on August 8, 2024
- Amylyx Pharmaceuticals Receives Orphan Drug Designation From the European Commission for AMX0035 for the Treatment of Wolfram Syndrome
- Amylyx Pharmaceuticals Announces Acquisition of Phase 3-ready GLP-1 Receptor Antagonist (Avexitide) with FDA Breakthrough Therapy Designation
More ▼